<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01147315</url>
  </required_header>
  <id_info>
    <org_study_id>BRD/08/10-H</org_study_id>
    <nct_id>NCT01147315</nct_id>
  </id_info>
  <brief_title>ORN Study: Curative Treatment of Osteoradionecrosis (ORN) With Hybrid Bone Substitution</brief_title>
  <acronym>ORN</acronym>
  <official_title>10 Patients Bicentric Prospective Study of Hybrid Bone Substitution With Calcium-phosphate Ceramic Biomaterial and Autologous Bone Marrow for Mandibular Osteoradionecrosis (ORN) Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of the study is the cure of osteoradionecrosis (ORN) at 12 months.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 18, 2009</start_date>
  <completion_date type="Actual">November 16, 2016</completion_date>
  <primary_completion_date type="Actual">November 16, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The cure of ORN</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of post operative pain at mandibular and bone marrow sampling site</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Possibility of secondary dental prosthetic devices</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CT semiology description of the treated area</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone regeneration</measure>
    <description>Bone regeneration: kinetics of formation of new bone and biomaterial resorption</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of hospital days</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety of hybrid bone substitution</measure>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Mandible</condition>
  <condition>Osteoradionecrosis</condition>
  <arm_group>
    <arm_group_label>Hybrid bone substitution</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hybrid bone substitution with calcium-phosphate ceramic biomaterial and autologous bone marrow</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hybrid bone substitution</intervention_name>
    <description>The patient will be treated by hybrid bone substitution with calcium-phosphate ceramic biomaterial and autologous bone marrow after necrosis exeresis</description>
    <arm_group_label>Hybrid bone substitution</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients (between 18 and 75 years) affiliated with an appropriate social
             security system, diagnosed as suffering from symptomatic ORN, radiologically
             confirmed, for which surgery is indicated

          -  Presence maximum of 2 outbreaks of ORN

          -  Oncological remission of the original tumor site for 1 year and for 3 years if the ORN
             is in the contact or close to the initial tumoral site

          -  ECOG performance status 0, 1 or 2

          -  ORN symptomatic accessible to the conservation of at least one cortical mandibular
             basilar

          -  Signed informed consent

        Exclusion Criteria:

          -  Oncological treatment

          -  Haematologic background

          -  Current bone necrosis consecutive or concurrent to taking bisphosphonates

          -  Extension of ORN does not allow the retention of a mandibular rod (bicortical form)

          -  Presence of fracture complicating ORN

          -  Bisphosphonates during the last year

          -  Contraindications to the removal of iliac or sternum bone marrow

          -  Contraindication for general anesthesia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olivier Malard, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nantes University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rennes University Hospital</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 17, 2010</study_first_submitted>
  <study_first_submitted_qc>June 17, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 22, 2010</study_first_posted>
  <last_update_submitted>April 5, 2018</last_update_submitted>
  <last_update_submitted_qc>April 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>mandibular osteoradionecrosis</keyword>
  <keyword>hybrid bone substitution</keyword>
  <keyword>calcium-phosphate ceramic biomaterial</keyword>
  <keyword>autologous bone marrow</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoradionecrosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium, Dietary</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

